Amoeba SA
PAR:ALMIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
New Work SE
XETRA:NWO
|
DE |
Amoeba SA
Short-Term Debt
Amoeba SA
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amoeba SA
PAR:ALMIB
|
Short-Term Debt
€600
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Robertet SA
PAR:RBT
|
Short-Term Debt
€6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Baikowski SA
PAR:ALBKK
|
Short-Term Debt
€2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sergeferrari Group SA
PAR:SEFER
|
Short-Term Debt
€932k
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-20%
|
|
|
Encres Dubuit SA
PAR:ALDUB
|
Short-Term Debt
€3k
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Amoeba SA
Glance View
Amoéba SA engages in developing, manufacturing and biological products. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes and currently employs 22 full-time employees. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.
See Also
What is Amoeba SA's Short-Term Debt?
Short-Term Debt
600
EUR
Based on the financial report for Dec 31, 2025, Amoeba SA's Short-Term Debt amounts to 600 EUR.
What is Amoeba SA's Short-Term Debt growth rate?
Short-Term Debt CAGR 3Y
0%
Over the last year, the Short-Term Debt growth was 20%.
